When do we need to perform a diagnostic lumbar puncture for neurometabolic diseases? Positive yield and retrospective analysis from a tertiary center

Turkish Journal of Pediatrics

Volumn 54, Issue 1, 2012, Pages 52-58

  Haliloǧlu, Göknur ^a   Vezir, Emine ^a   Baydar, Leyla ^a   Önol, Saniye ^a   Sivri, Serap ^a   Coşkun, Turgay ^a   Topçu, Meral ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cerebrospinal fluid metabolites; Diagnostic lumbar puncture; Neurotransmitter metabolism

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; LEVODOPA; SUCCINATE SEMIALDEHYDE DEHYDROGENASE;

ADOLESCENT; ARTICLE; CEREBROSPINAL FLUID EXAMINATION; CHILD; CLINICAL FEATURE; CONSANGUINITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSTONIA; ENZYME DEFICIENCY; EYE MOVEMENT DISORDER; FEMALE; FOLIC ACID DEFICIENCY; GLYCINE ENCEPHALOPATHY; HUMAN; INFANT; LEVODOPA RESPONSIVE DYSTONIA; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; METABOLIC ENCEPHALOPATHY; NEUROIMAGING; NYSTAGMUS; OCULOGYRIC CRISIS; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PYRIDOXAL PHOSPHATE DEPENDENT SEIZURE; RETROSPECTIVE STUDY; SCHOOL CHILD; SEIZURE; SERINE BIOSYNTHESIS DEFECT; TERTIARY HEALTH CARE;

ADOLESCENT; AMINO ACID METABOLISM, INBORN ERRORS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CIRCADIAN RHYTHM; CONSANGUINITY; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; INFANT; MALE; NEUROIMAGING; RETROSPECTIVE STUDIES; SPINAL PUNCTURE; STATISTICS, NONPARAMETRIC;

EID: 84858853469     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Pearl PL, Taylor JL, Trzcinski S, Sokohl A. The pediatric neurotransmitter disorders. J Child Neurol 2007; 22: 606-616.
2. Pearl PL, Capp PK, Novotny EJ, Gibson KM. Inherited disorders of neurotransmitters in children and adults. Clinical Biochem 2005; 38: 1051-1058.
3. DeVivo DC, Johnston MV (eds). Pediatric Neurotransmitter Disorders: A Multidisciplinary Approach. Vol 54. Ann Neurol 2003; S12-109.
4. Assmann B, Surtees R, Hoffmann GF. Approach to the diagnosis of neurotransmitter diseases exemplified by the differential diagnosis of childhood-onset dystonia. Ann Neurol 2003; 54 (Suppl): S18-24.
5. Pons R. The phenotypic spectrum of pediatric neurotransmitter diseases and infantile parkinsonism. J Inherit Metab Dis 2009; 32: 321-332.
6. Garcia-Cazorla A, Wolf NI, Serrano M, et al. Inborn errors of metabolism and motor disturbances in children. J Inherit Metab Dis 2009; 32: 618-629.
7. Swoboda KJ, Hyland K. Diagnosis and treatment of neurotransmitter-related disorders. Neurol Clin 2002; 20: 1143-1161.
8. Hyland K. The lumbar puncture for diagnosis of pediatric neurotransmitter diseases. Ann Neurol 2003; 54: 13-17.
9. Kruesi MJ, Swedo SE, Hamburger SD, et al. Concentration gradient of CSF monoamine metabolites in children and adolescents. Biol Psychiatry 1988; 24: 507-514.
10. Howells DW, Hyland K. Direct analysis of tetrahydrobiopterin in cerebrospinal fluid by high-performance liquid chromatography with redox electrochemistry: prevention of autoxidation during storage and analysis. Clin Chim Acta 1987; 167: 23-30.
11. Hyland K, Surtees RA, Heales SJ, et al. Cerebrospinal fluid concentrations of pterins and metabolites of serotonin and dopamine in a pediatric reference population. Pediatr Res 1993; 34: 10-14.
12. Hyland K, Peterschmitt MJ, Soull JS, et al. Confusing CSF neurochemical picture suggesting 6-pyruvoyltetrahydropterin synthase deficiency in neonates with probable hypoxic-ischemic encephalopathy. J Inherit Metab Dis 1999; 22: 18.
13. Shevell M, Ashwal S, Donley D, et al. Practice parameter: evaluation of child with global developmental delay: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2003; 60: 367-380.
14. Henderson HE, Goodman R, Schram J, Diamond E, Daneel A. Biochemical screening for inherited metabolic disorders in the mentally retarded. S Afr Med J 1981; 60: 731-733.
15. Reinecke CJ, Mienie LJ, Hitzeroth HW, Op't Hof J. Screening for inborn errors of metabolism among mentally retarded patients. Outcome of a survey at the Witrand Care and Rehabilitation Centre. S Afr Med J 1983; 63: 14-16.
16. Matilainen R, Airaksinen E, Mononen T, Launiala K, Kaariainen R. A population-based study on the causes of mild and severe mental retardation. Acta Pediatr 1995; 84: 261-266.
17. Jaffe M, Borochowitz Z, Dar H. Diagnostic approach to the etiology of mental retardation. Isr J Med Sci 1984; 20: 136-140.
18. Majnemer A, Shevell MI. Diagnostic yield of the neurologic assessment of the developmentally delayed child. J Pediatr 1995; 127: 193-199.
19. Shevell MI, Majnemer A, Rosenbaum P, Abrahamowicz M. Etiologic yield of subspecialists' evaluation of young children with global developmental delay. J Pediatr 2000; 136: 593-598.
20. Pearl PL, Gibson KM, Acosta MT, et al. Clinical spectrum of succinic semialdehyde dehydrogenase deficiency. Neurology 2003; 60: 1413-1417.
21. Hyland K, Surtees RA, Rodeck C, Clayton PT. Aromatic L-amino acid decarboxylase deficiency: Clinical features, diagnosis, and treatment of a new inborn error of neurotransmitter amine synthesis. Neurology 1992; 42: 1980-1988.
22. Ramaekers VT, Rothenberg SP, Sequeira JM, et al. Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. N Engl J Med 2005; 352: 1948-1950.